379:
Diagnosis of androgenic deficiency in males is based on symptoms together with at least two measurements of testosterone done first thing in the morning after a period of not eating. In those without symptoms, testing is not generally recommended. Androgen deficiency is not usually checked for
1309:
Guay, A.; Munarriz, R.; Jacobson, J.; Talakoub, L.; Traish, A.; Quirk, F.; Goldstein, I.; Spark, R. (April 24, 2004). "Serum androgen levels in healthy premenopausal women with and without sexual dysfunction: Part A. Serum androgen levels in women aged 20β49 years with no complaints of sexual
888:
457:
1652:
Barratt, Christopher L R; BjΓΆrndahl, Lars; De Jonge, Christopher J; Lamb, Dolores J; Osorio
Martini, Francisco; McLachlan, Robert; Oates, Robert D; van der Poel, Sheryl; St John, Bianca; Sigman, Mark; Sokol, Rebecca; Tournaye, Herman (2017-11-01).
450:
1756:"Testosterone Products: Drug Safety Communication β FDA Cautions About Using Testosterone Products for Low Testosterone Due to Aging; Requires Labeling Change to Inform of Possible Increased Risk of Heart Attack And Stroke"
443:
1396:"Re: Christina Wang, Eberhard Nieschlag, Ronald Swerdloff, et al. Investigation, Treatment, and Monitoring of Late-Onset Hypogonadism in Males: ISA, ISSAM, EAU, EAA, and ASA Recommendations. Eur Urol 2009;55:121β30"
73:), and is dependent on various factors including androgen receptor abundance, sensitivity and function. Androgen deficiency is associated with lack of energy and motivation, depression, lack of desire (
436:. The FDA has required that testosterone pharmaceutical labels include warning information about the possibility of an increased risk of heart attacks and stroke.
1865:
1655:"The diagnosis of male infertility: an analysis of the evidence to support the development of global WHO guidanceβchallenges and future research opportunities"
1800:
1993:
1908:
1903:
1898:
413:
1629:
1893:
1755:
1354:"Corrigendum to: "Testosterone Therapy in Adult Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline""
1039:
Bhasin, S; Brito, JP; Cunningham, GR; Hayes, FJ; Hodis, HN; Matsumoto, AM; Snyder, PJ; Swerdloff, RS; Wu, FC; Yialamas, MA (1 May 2018).
2079:
232:, with some mixed atrophy of type II (fast-twitch/glycolytic) muscle fibres. Treatment is hormone replacement therapy of testosterone.
2069:
2074:
2048:
2013:
1888:
1444:, Ch. 38 Endocrine myopathies. Oxford Textbooks in Clinical Neurology (Oxford, 2014; online edn, Oxford Academic, 1 May 2014),
360:
2018:
1793:
409:
316:
293:
2023:
1988:
307:
2084:
2033:
2003:
1860:
425:
324:
78:
395:
2043:
1924:
1440:
Needham, Merrilee, and Frank
Mastaglia, 'Endocrine myopathies', in David Hilton-Jones, and Martin R. Turner (eds),
872:
662:
1870:
1830:
1825:
1786:
941:
781:
741:
667:
630:
593:
588:
492:
433:
429:
389:
1274:
Guay, A; Traish, A (October 2010). "Testosterone therapy in women with androgen deficiency: Its time has come".
1998:
904:
856:
508:
2028:
1010:
797:
761:
920:
840:
813:
770:
217:
174:
736:
625:
212:
showed low volitional contraction of short duration polyphasic units. Muscle biopsy showed evidence of
65:(FAIS), although it can happen in both sexes. Androgenic activity is mediated by androgens (a class of
2008:
936:
757:
2038:
487:
1462:
Orrell, R W; Woodrow, D F; Barrett, M C; Press, M; Dick, D J; Rowe, R C; Lane, R J (August 1995).
1201:
1961:
1710:
Wierman ME, Arlt W, Basson R, Davis SR, Miller KK, Murad MH, Rosner W, Santoro N (October 2014).
1335:
1291:
1256:
1041:"Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline"
646:
609:
524:
371:
may also be a factor in the development of hypoandrogenism, as androgen levels decline with age.
1880:
1733:
1692:
1674:
1625:
1619:
1600:
1559:
1532:
1524:
1493:
1475:
1423:
1415:
1373:
1327:
1283:
1248:
1213:
1182:
1147:
1103:
1062:
344:
332:
312:
260:
248:
244:
142:
138:
134:
70:
54:
960:
Men produce about 3 to 11 mg of testosterone per day (mean 7 mg/day in young men).
44:
Hypoandrogenism, androgen deficiency syndrome, men with hypogonadism, testosterone deficiency
1983:
1978:
1809:
1723:
1712:"Androgen therapy in women: a reappraisal: an Endocrine Society clinical practice guideline"
1682:
1666:
1590:
1483:
1445:
1407:
1365:
1319:
1240:
1174:
1137:
1093:
1052:
990:
985:
364:
209:
188:
or (hypogonadotropic) hypogonadism with myopathy. Signs and symptoms include elevated serum
166:
66:
1654:
1973:
1949:
1817:
1000:
540:
403:
302:
276:
229:
197:
189:
61:
activity in the body. Androgen deficiency most commonly affects women, and is also called
1449:
1687:
1488:
1463:
716:
252:
193:
158:
1595:
1578:
1244:
1142:
1125:
287:
Hypoandrogenism is primarily caused by either dysfunction, failure, or absence of the
2063:
1956:
1835:
995:
205:
1339:
1295:
1944:
1260:
1005:
556:
417:
340:
320:
298:
268:
224:) infiltrating degenerating fibres, and an increase in adipose and fibrous tissue (
170:
162:
114:
1395:
1411:
1080:
Rivera-Woll, L. M.; Papalia, M.; Davis, S. R.; Burger, H. G. (October 1, 2004).
572:
264:
118:
98:
1178:
17:
221:
1678:
1528:
1479:
1419:
1377:
1369:
1202:"Testosterone replacement therapy for female androgen insufficiency syndrome"
311:). This in turn can be caused by a multitude of different stimuli, including
1670:
1512:
1353:
1323:
1098:
1081:
348:
240:
146:
122:
94:
1737:
1696:
1604:
1563:
1536:
1427:
1331:
1287:
1252:
1217:
1186:
1151:
1107:
1066:
1497:
1082:"Androgen insufficiency in women: diagnostic and therapeutic implications"
1057:
1040:
1845:
1728:
1711:
980:
399:
225:
213:
201:
181:
154:
150:
110:
102:
58:
1165:
Braunstein, Glenn D. (July 1, 2006). "Androgen insufficiency in women".
1231:
Davison, Sonia L; Davis, Susan R (June 1, 2003). "Androgens in women".
368:
336:
130:
279:
may be present in both sexes in cases of severe androgen deficiency.
272:
236:
126:
90:
74:
1778:
359:, and many others. It may also be the result of conditions such as
465:
Androgen replacement therapy formulations and dosages used in men
352:
328:
288:
256:
106:
428:(FDA) stated in 2015 that neither the benefits nor the safety of
356:
1782:
964:= Never marketed. = No longer used and/or no longer marketed.
275:
mass. As estrogens are synthesized from androgens, symptoms of
1760:
1126:"Androgen insufficiency in women: summary of critical issues"
1233:
The
Journal of Steroid Biochemistry and Molecular Biology
1513:"Hypogonadotropic Hypogonadism in a Boy with Myopathy"
1358:
The
Journal of Clinical Endocrinology & Metabolism
89:
Symptoms of the condition in males consist of loss of
1579:"The hypoandrogenic woman: pathophysiologic overview"
1511:
Haq, T.; Pathan, M. F.; Ikhtaire, S. (January 2016).
1716:
The
Journal of Clinical Endocrinology and Metabolism
1394:
Ponholzer, Anton; Madersbacher, Stephan (May 2009).
1045:
The
Journal of Clinical Endocrinology and Metabolism
228:). A predominance of type I (slow-twitch/oxidative)
220:, some fibre splitting, chronic inflammatory cells (
1937:
1917:
1879:
1853:
1844:
1816:
1206:
International
Journal of Pharmaceutical Compounding
40:
35:
402:in those with symptoms. Treatment mostly improves
762:
235:In females, hypoandrogenism consist of loss of
771:
1794:
451:
204:), a burning sensation in the feet at night,
184:can result from androgen deficiency known as
8:
1866:17Ξ²-Hydroxysteroid dehydrogenase deficiency
1312:International Journal of Impotence Research
931:600β1,000 mg 1×/12β20 weeks
915:750β1,000 mg 1×/10β14 weeks
718:
1850:
1801:
1787:
1779:
1749:
1747:
1442:Oxford Textbook of Neuromuscular Disorders
458:
444:
438:
32:
1994:Cytochrome P450 oxidoreductase deficiency
1727:
1686:
1594:
1487:
1141:
1097:
1056:
1034:
1032:
1030:
1028:
1026:
519:40β80 mg/2β4× day (with meals)
1909:Familial male-limited precocious puberty
1904:Complete androgen insensitivity syndrome
1468:Journal of the Royal Society of Medicine
1276:Current Opinion in Investigational Drugs
177:, may be concurrently present in males.
1899:Partial androgen insensitivity syndrome
1022:
955:
503:400β800 mg/day (in divided doses)
77:), and in more severe cases changes in
1119:
1117:
899:50β250 mg 1×/2β4 weeks
883:50β200 mg 1×/3β5 weeks
439:
63:Female androgen insufficiency syndrome
1894:Mild androgen insensitivity syndrome
1389:
1387:
1124:Braunstein, Glenn D (April 1, 2002).
27:Lack of androgen hormones in the body
7:
434:low testosterone levels due to aging
325:enzymatic defects of steroidogenesis
1624:. Humana Press. pp. 365β379.
1464:"Testosterone deficiency myopathy"
1450:10.1093/med/9780199698073.003.0034
952:150β1,200 mg/3β6 months
545:Halotestin, Ora-Testryl, Ultandren
25:
1167:Growth Hormone & IGF Research
867:50β100 mg 1x/1β2 weeks
851:50β250 mg 1x/1β4 weeks
824:50β250 mg 1x/1β4 weeks
683:Androderm, AndroPatch, TestoPatch
786:Andronaq, Sterotate, Virosterone
208:, and impaired fasting glucose.
186:testosterone deficiency myopathy
69:with varying affinities for the
2049:Hypergonadotropic hypergonadism
2014:Estrogen insensitivity syndrome
1889:Androgen insensitivity syndrome
1621:Androgens in Health and Disease
1517:Mymensingh Medical Journal: MMJ
767:Tooltip intramuscular injection
361:androgen insensitivity syndrome
2019:Hypergonadotropic hypogonadism
1550:Jakiel G, Baran A (2005). "".
1406:(5): e92, author reply e93-4.
776:Tooltip subcutaneous injection
410:Gonadotropin-releasing hormone
57:characterized by insufficient
1:
2024:Hypogonadotropic hypogonadism
1989:Postorgasmic illness syndrome
1596:10.1016/S0015-0282(02)03003-0
1245:10.1016/S0960-0760(03)00204-8
1143:10.1016/S0015-0282(02)02962-X
808:10β50 mg 2β3×/week
792:10β50 mg 2β3×/week
420:may be given (in the case of
79:secondary sex characteristics
2034:Estrogen-dependent condition
2004:Androgen-dependent condition
1412:10.1016/j.eururo.2008.11.053
835:50β100 mg 1×/week
426:Food and Drug Administration
380:diagnosis in healthy women.
604:5β10 mg 1β4×/day
529:Android, Metandren, Testred
396:hormone replacement therapy
165:. In addition, symptoms of
2101:
2080:Animal reproductive system
2044:Gonadotropin insensitivity
1925:Sertoli cell-only syndrome
1618:Bremner WJ (27 May 2003).
1577:Bachmann GA (April 2002).
1179:10.1016/j.ghir.2006.03.009
893:Sustanon 100, Sustanon 250
873:Testosterone phenylacetate
756:
672:AndroGel, Testim, TestoGel
432:have been established for
387:
2070:Endocrine gonad disorders
1871:Aromatase excess syndrome
1861:5Ξ±-reductase 2 deficiency
1831:Premature ovarian failure
1826:Polycystic ovary syndrome
1659:Human Reproduction Update
1086:Human Reproduction Update
956:
889:Mixed testosterone esters
812:
752:40 mg 2β3×/day
666:
661:
624:
587:
486:
394:Treatment may consist of
390:Testosterone (medication)
1999:Cytochrome b5 deficiency
1452:. Retrieved 29 May 2023.
1364:(7): e2843. 2021-05-17.
905:Testosterone undecanoate
857:Testosterone isobutyrate
651:Metandren, Oreton Methyl
614:Metandren, Oreton Methyl
509:Testosterone undecanoate
267:), insomnia, headaches,
2029:Fertile eunuch syndrome
1583:Fertility and Sterility
1324:10.1038/sj.ijir.3901178
1130:Fertility and Sterility
1011:Late-onset hypogonadism
798:Testosterone propionate
746:Rektandron, Testosteron
641:30 mg 2×/day
297:) or impairment of the
263:(e.g., hot flashes and
2075:Male genital disorders
1754:Staff (3 March 2015).
1370:10.1210/clinem/dgab306
921:Testosterone buciclate
841:Testosterone cypionate
814:Testosterone enanthate
424:hypoandrogenism). The
253:vaginal vasocongestion
1671:10.1093/humupd/dmx021
1552:Endokrynologia Polska
1200:Tan, RS (July 2005).
1099:10.1093/humupd/dmh037
1058:10.1210/jc.2018-00229
255:(which can result in
2009:Aromatase deficiency
1729:10.1210/jc.2014-2260
877:Perandren, Androject
731:100β250 mg/day
180:In males, a type of
2085:Intersex variations
2039:Premature thelarche
711:30β120 mg/day
689:2.5β15 mg/day
678:25β125 mg/day
583:25β150 mg/day
466:
101:, shrinkage of the
51:Androgen deficiency
36:Androgen deficiency
1962:Precocious puberty
1589:(Suppl 4): S72β6.
928:Aqueous suspension
864:Aqueous suspension
789:Aqueous suspension
647:Methyltestosterone
620:10β30 mg/day
610:Methyltestosterone
535:10β50 mg/day
525:Methyltestosterone
323:insensitivity and
313:genetic conditions
261:vasomotor symptoms
143:vasomotor symptoms
85:Signs and symptoms
2057:
2056:
1933:
1932:
1881:Androgen receptor
1631:978-1-58829-029-8
972:
971:
845:Depo-Testosterone
708:Axillary solution
686:Non-scrotal patch
657:5β25 mg/day
567:5β15 mg/day
551:5β20 mg/day
476:Major brand names
294:hypergonadotropic
117:(e.g., decreased
71:androgen receptor
55:medical condition
48:
47:
30:Medical condition
16:(Redirected from
2092:
1984:Hyperestrogenism
1979:Hyperandrogenism
1851:
1810:Gonadal disorder
1803:
1796:
1789:
1780:
1773:
1772:
1770:
1768:
1751:
1742:
1741:
1731:
1722:(10): 3489β510.
1707:
1701:
1700:
1690:
1649:
1643:
1642:
1640:
1638:
1615:
1609:
1608:
1598:
1574:
1568:
1567:
1547:
1541:
1540:
1508:
1502:
1501:
1491:
1459:
1453:
1438:
1432:
1431:
1400:European Urology
1391:
1382:
1381:
1350:
1344:
1343:
1306:
1300:
1299:
1271:
1265:
1264:
1228:
1222:
1221:
1197:
1191:
1190:
1162:
1156:
1155:
1145:
1121:
1112:
1111:
1101:
1077:
1071:
1070:
1060:
1051:(5): 1715β1744.
1036:
991:Hyperestrogenism
986:Hyperandrogenism
777:
773:
768:
764:
720:
717:Androstanolone (
700:4β6 mg/day
513:Andriol, Jatenzo
467:
460:
453:
446:
422:hypogonadotropic
365:hyperestrogenism
308:hypogonadotropic
167:hyperestrogenism
67:steroid hormones
33:
21:
2100:
2099:
2095:
2094:
2093:
2091:
2090:
2089:
2060:
2059:
2058:
2053:
1974:Hypoestrogenism
1969:Hypoandrogenism
1950:Delayed puberty
1929:
1913:
1875:
1840:
1812:
1807:
1777:
1776:
1766:
1764:
1753:
1752:
1745:
1709:
1708:
1704:
1651:
1650:
1646:
1636:
1634:
1632:
1617:
1616:
1612:
1576:
1575:
1571:
1549:
1548:
1544:
1510:
1509:
1505:
1461:
1460:
1456:
1439:
1435:
1393:
1392:
1385:
1352:
1351:
1347:
1308:
1307:
1303:
1282:(10): 1116β26.
1273:
1272:
1268:
1230:
1229:
1225:
1199:
1198:
1194:
1164:
1163:
1159:
1123:
1122:
1115:
1079:
1078:
1074:
1038:
1037:
1024:
1019:
1001:Hypoestrogenism
977:
775:
766:
541:Fluoxymesterone
464:
404:sexual function
392:
386:
377:
303:pituitary gland
285:
277:hypoestrogenism
200:(predominantly
198:muscle weakness
115:masculinization
87:
31:
28:
23:
22:
18:Hypoandrogenism
15:
12:
11:
5:
2098:
2096:
2088:
2087:
2082:
2077:
2072:
2062:
2061:
2055:
2054:
2052:
2051:
2046:
2041:
2036:
2031:
2026:
2021:
2016:
2011:
2006:
2001:
1996:
1991:
1986:
1981:
1976:
1971:
1966:
1965:
1964:
1954:
1953:
1952:
1941:
1939:
1935:
1934:
1931:
1930:
1928:
1927:
1921:
1919:
1915:
1914:
1912:
1911:
1906:
1901:
1896:
1891:
1885:
1883:
1877:
1876:
1874:
1873:
1868:
1863:
1857:
1855:
1848:
1842:
1841:
1839:
1838:
1833:
1828:
1822:
1820:
1814:
1813:
1808:
1806:
1805:
1798:
1791:
1783:
1775:
1774:
1743:
1702:
1665:(6): 660β680.
1644:
1630:
1610:
1569:
1558:(6): 1016β20.
1542:
1523:(1): 186β189.
1503:
1474:(8): 454β456.
1454:
1433:
1383:
1345:
1318:(2): 112β120.
1310:dysfunction".
1301:
1266:
1239:(2): 363β366.
1223:
1192:
1157:
1113:
1092:(5): 421β432.
1072:
1021:
1020:
1018:
1015:
1014:
1013:
1008:
1003:
998:
993:
988:
983:
976:
973:
970:
969:
968:See template.
954:
953:
950:
947:
944:
939:
933:
932:
929:
926:
923:
917:
916:
913:
910:
907:
901:
900:
897:
894:
891:
885:
884:
881:
878:
875:
869:
868:
865:
862:
861:Agovirin Depot
859:
853:
852:
849:
846:
843:
837:
836:
833:
830:
826:
825:
822:
819:
816:
810:
809:
806:
803:
800:
794:
793:
790:
787:
784:
779:
754:
753:
750:
747:
744:
739:
733:
732:
729:
726:
723:
713:
712:
709:
706:
702:
701:
698:
695:
691:
690:
687:
684:
680:
679:
676:
673:
670:
665:
659:
658:
655:
652:
649:
643:
642:
639:
636:
633:
628:
622:
621:
618:
615:
612:
606:
605:
602:
599:
596:
591:
585:
584:
581:
578:
575:
569:
568:
565:
562:
559:
553:
552:
549:
546:
543:
537:
536:
533:
530:
527:
521:
520:
517:
514:
511:
505:
504:
501:
498:
495:
490:
484:
483:
480:
477:
474:
471:
463:
462:
455:
448:
440:
385:
382:
376:
373:
284:
281:
194:muscle wasting
192:, symmetrical
159:cardiomyopathy
86:
83:
46:
45:
42:
38:
37:
29:
26:
24:
14:
13:
10:
9:
6:
4:
3:
2:
2097:
2086:
2083:
2081:
2078:
2076:
2073:
2071:
2068:
2067:
2065:
2050:
2047:
2045:
2042:
2040:
2037:
2035:
2032:
2030:
2027:
2025:
2022:
2020:
2017:
2015:
2012:
2010:
2007:
2005:
2002:
2000:
1997:
1995:
1992:
1990:
1987:
1985:
1982:
1980:
1977:
1975:
1972:
1970:
1967:
1963:
1960:
1959:
1958:
1957:Hypergonadism
1955:
1951:
1948:
1947:
1946:
1943:
1942:
1940:
1936:
1926:
1923:
1922:
1920:
1916:
1910:
1907:
1905:
1902:
1900:
1897:
1895:
1892:
1890:
1887:
1886:
1884:
1882:
1878:
1872:
1869:
1867:
1864:
1862:
1859:
1858:
1856:
1852:
1849:
1847:
1843:
1837:
1836:Hyperthecosis
1834:
1832:
1829:
1827:
1824:
1823:
1821:
1819:
1815:
1811:
1804:
1799:
1797:
1792:
1790:
1785:
1784:
1781:
1763:
1762:
1757:
1750:
1748:
1744:
1739:
1735:
1730:
1725:
1721:
1717:
1713:
1706:
1703:
1698:
1694:
1689:
1684:
1680:
1676:
1672:
1668:
1664:
1660:
1656:
1648:
1645:
1633:
1627:
1623:
1622:
1614:
1611:
1606:
1602:
1597:
1592:
1588:
1584:
1580:
1573:
1570:
1565:
1561:
1557:
1554:(in Polish).
1553:
1546:
1543:
1538:
1534:
1530:
1526:
1522:
1518:
1514:
1507:
1504:
1499:
1495:
1490:
1485:
1481:
1477:
1473:
1469:
1465:
1458:
1455:
1451:
1447:
1443:
1437:
1434:
1429:
1425:
1421:
1417:
1413:
1409:
1405:
1401:
1397:
1390:
1388:
1384:
1379:
1375:
1371:
1367:
1363:
1359:
1355:
1349:
1346:
1341:
1337:
1333:
1329:
1325:
1321:
1317:
1313:
1305:
1302:
1297:
1293:
1289:
1285:
1281:
1277:
1270:
1267:
1262:
1258:
1254:
1250:
1246:
1242:
1238:
1234:
1227:
1224:
1219:
1215:
1212:(4): 259β64.
1211:
1207:
1203:
1196:
1193:
1188:
1184:
1180:
1176:
1172:
1168:
1161:
1158:
1153:
1149:
1144:
1139:
1135:
1131:
1127:
1120:
1118:
1114:
1109:
1105:
1100:
1095:
1091:
1087:
1083:
1076:
1073:
1068:
1064:
1059:
1054:
1050:
1046:
1042:
1035:
1033:
1031:
1029:
1027:
1023:
1016:
1012:
1009:
1007:
1004:
1002:
999:
997:
996:Hypergonadism
994:
992:
989:
987:
984:
982:
979:
978:
974:
967:
963:
959:
951:
948:
945:
943:
940:
938:
935:
934:
930:
927:
924:
922:
919:
918:
914:
911:
909:Aveed, Nebido
908:
906:
903:
902:
898:
895:
892:
890:
887:
886:
882:
879:
876:
874:
871:
870:
866:
863:
860:
858:
855:
854:
850:
847:
844:
842:
839:
838:
834:
832:Auto-injector
831:
828:
827:
823:
820:
817:
815:
811:
807:
804:
801:
799:
796:
795:
791:
788:
785:
783:
780:
774:
765:
759:
755:
751:
748:
745:
743:
740:
738:
735:
734:
730:
727:
724:
722:
715:
714:
710:
707:
704:
703:
699:
697:Scrotal patch
696:
693:
692:
688:
685:
682:
681:
677:
674:
671:
669:
664:
660:
656:
653:
650:
648:
645:
644:
640:
637:
634:
632:
629:
627:
623:
619:
616:
613:
611:
608:
607:
603:
600:
597:
595:
592:
590:
586:
582:
579:
576:
574:
571:
570:
566:
563:
560:
558:
555:
554:
550:
547:
544:
542:
539:
538:
534:
531:
528:
526:
523:
522:
518:
515:
512:
510:
507:
506:
502:
499:
496:
494:
491:
489:
485:
481:
478:
475:
472:
469:
468:
461:
456:
454:
449:
447:
442:
441:
437:
435:
431:
427:
423:
419:
418:gonadotropins
415:
414:GnRH agonists
411:
407:
405:
401:
397:
391:
383:
381:
374:
372:
370:
366:
362:
358:
354:
350:
346:
342:
338:
334:
330:
326:
322:
318:
314:
310:
309:
304:
300:
296:
295:
290:
282:
280:
278:
274:
270:
266:
262:
258:
254:
250:
246:
242:
238:
233:
231:
230:muscle fibres
227:
223:
219:
215:
211:
207:
206:waddling gait
203:
199:
195:
191:
187:
183:
178:
176:
172:
168:
164:
160:
156:
152:
148:
144:
140:
136:
132:
128:
125:growth), low
124:
120:
116:
113:, diminished
112:
108:
104:
100:
96:
92:
84:
82:
80:
76:
72:
68:
64:
60:
56:
52:
43:
39:
34:
19:
1968:
1945:Hypogonadism
1765:. Retrieved
1759:
1719:
1715:
1705:
1662:
1658:
1647:
1635:. Retrieved
1620:
1613:
1586:
1582:
1572:
1555:
1551:
1545:
1520:
1516:
1506:
1471:
1467:
1457:
1441:
1436:
1403:
1399:
1361:
1357:
1348:
1315:
1311:
1304:
1279:
1275:
1269:
1236:
1232:
1226:
1209:
1205:
1195:
1170:
1166:
1160:
1133:
1129:
1089:
1085:
1075:
1048:
1044:
1006:Hypogonadism
965:
961:
957:
942:Testosterone
912:Oil solution
896:Oil solution
880:Oil solution
848:Oil solution
821:Oil solution
805:Oil solution
782:Testosterone
742:Testosterone
668:Testosterone
631:Testosterone
594:Testosterone
557:Metandienone
493:Testosterone
430:testosterone
421:
408:
393:
378:
341:autoimmunity
321:gonadotropin
306:
299:hypothalamus
292:
286:
271:and reduced
269:osteoporosis
265:palpitations
239:, decreased
234:
218:regeneration
185:
179:
175:feminization
171:gynecomastia
163:osteoporosis
88:
62:
50:
49:
1173:: 109β117.
818:Delatestryl
749:Suppository
663:Transdermal
573:Mesterolone
222:macrophages
214:myonecrosis
147:hot flashes
99:infertility
41:Other names
2064:Categories
1846:Testicular
1017:References
962:Footnotes:
802:Testoviron
589:Sublingual
473:Medication
406:in males.
388:See also:
349:infections
245:depression
169:, such as
135:depression
59:androgenic
1854:Enzymatic
1679:1355-4786
1529:1022-4742
1480:0141-0768
1420:0302-2838
1378:0021-972X
1136:: 94β99.
758:Injection
725:Andractim
694:Testoderm
400:androgens
384:Treatment
375:Diagnosis
345:radiation
241:body hair
155:headaches
123:body hair
103:testicles
95:impotence
1738:25279570
1697:28981651
1605:12007907
1564:16821229
1537:26931274
1428:19081175
1340:22139942
1332:14999217
1296:24910370
1288:20872314
1253:12943723
1218:23925049
1187:16631401
1152:12007911
1108:15297435
1067:29562364
981:Androgen
975:See also
966:Sources:
946:Testopel
598:Testoral
577:Proviron
561:Dianabol
243:growth,
226:fibrosis
202:proximal
182:myopathy
151:insomnia
111:prostate
1938:General
1818:Ovarian
1767:5 March
1688:5850791
1637:11 June
1498:7562829
1489:1295300
1261:8048483
937:Implant
829:Xyosted
635:Striant
516:Capsule
482:Dosage
412:(GnRH)/
369:Old age
337:surgery
315:(e.g.,
249:fatigue
139:fatigue
131:anxiety
1736:
1695:
1685:
1677:
1628:
1603:
1562:
1535:
1527:
1496:
1486:
1478:
1426:
1418:
1376:
1338:
1330:
1294:
1286:
1259:
1251:
1216:
1185:
1150:
1106:
1065:
958:Notes:
949:Pellet
737:Rectal
705:Axiron
654:Tablet
638:Tablet
626:Buccal
617:Tablet
601:Tablet
580:Tablet
564:Tablet
548:Tablet
532:Tablet
500:Tablet
353:toxins
333:trauma
329:tumors
289:gonads
283:Causes
273:muscle
257:cramps
237:libido
129:mass,
127:muscle
119:facial
109:, and
91:libido
75:libido
1918:Other
1336:S2CID
1292:S2CID
1257:S2CID
470:Route
398:with
357:drugs
107:penis
53:is a
1769:2015
1734:PMID
1693:PMID
1675:ISSN
1639:2012
1626:ISBN
1601:PMID
1560:PMID
1533:PMID
1525:ISSN
1494:PMID
1476:ISSN
1424:PMID
1416:ISSN
1374:ISSN
1328:PMID
1284:PMID
1249:PMID
1214:PMID
1183:PMID
1148:PMID
1104:PMID
1063:PMID
488:Oral
479:Form
317:GnRH
216:and
196:and
173:and
161:and
121:and
1761:FDA
1724:doi
1683:PMC
1667:doi
1591:doi
1484:PMC
1446:doi
1408:doi
1366:doi
1362:106
1320:doi
1241:doi
1175:doi
1138:doi
1094:doi
1053:doi
1049:103
769:or
728:Gel
719:DHT
675:Gel
416:or
363:or
327:),
301:or
259:),
210:EMG
149:),
2066::
1758:.
1746:^
1732:.
1720:99
1718:.
1714:.
1691:.
1681:.
1673:.
1663:23
1661:.
1657:.
1599:.
1587:77
1585:.
1581:.
1556:56
1531:.
1521:25
1519:.
1515:.
1492:.
1482:.
1472:88
1470:.
1466:.
1422:.
1414:.
1404:55
1402:.
1398:.
1386:^
1372:.
1360:.
1356:.
1334:.
1326:.
1316:16
1314:.
1290:.
1280:11
1278:.
1255:.
1247:.
1237:85
1235:.
1208:.
1204:.
1181:.
1171:16
1169:.
1146:.
1134:77
1132:.
1128:.
1116:^
1102:.
1090:10
1088:.
1084:.
1061:.
1047:.
1043:.
1025:^
772:SC
763:IM
367:.
355:,
351:,
347:,
343:,
339:,
335:,
331:,
251:,
247:,
190:CK
157:,
153:,
141:,
137:,
133:,
105:,
97:,
93:,
81:.
1802:e
1795:t
1788:v
1771:.
1740:.
1726::
1699:.
1669::
1641:.
1607:.
1593::
1566:.
1539:.
1500:.
1448::
1430:.
1410::
1380:.
1368::
1342:.
1322::
1298:.
1263:.
1243::
1220:.
1210:9
1189:.
1177::
1154:.
1140::
1110:.
1096::
1069:.
1055::
925:β
778:)
760:(
721:)
497:β
459:e
452:t
445:v
319:/
305:(
291:(
145:(
20:)
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.